Extracellular Vesicle-Based Therapeutics in Neurological Disorders

Area of Science:

• Neuroscience
• Biotechnology
• Nanomedicine

Background:

• Neurological diseases are leading causes of death and disability worldwide.
• Limited drug options and poor blood-brain barrier penetration hinder effective neurological disorder treatment.
• Extracellular vesicles (EVs) have emerged as significant players in physiological and pathological processes relevant to neurological diseases.

Purpose of the Study:

• To review preclinical strategies for developing extracellular vesicle-based therapeutics for neurological disorders.
• To discuss the challenges and limitations in the clinical application of EV therapeutics.
• To highlight the potential of EVs as drug delivery systems for neurological conditions, leveraging nanomedicine advancements.

Main Methods:

• Review of preclinical research on extracellular vesicle therapeutics for neurological diseases.
• Analysis of nanomedicine approaches for enhancing EV drug delivery across the blood-brain barrier.
• Examination of current obstacles to the clinical translation of EV-based therapies.

Main Results:

• Extracellular vesicles are increasingly recognized for their therapeutic potential in neurological disorders.
• Nanomedicine has advanced the use of EVs as sophisticated drug delivery systems.
• Significant challenges remain in translating promising preclinical EV strategies into effective clinical treatments.

Conclusions:

• Extracellular vesicles represent a promising frontier for treating neurological diseases.
• Overcoming clinical application struggles is crucial for realizing the full therapeutic potential of EVs.
• Continued research integrating nanomedicine and EV biology is essential for advancing neurological disorder treatments.